Free shipping on all orders over $ 500

AZD3463

Cat. No. M2109

All AbMole products are for research use only, cannot be used for human consumption.

AZD3463 Structure
Synonym:

ALK/IGF1R inhibitor

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 54 In stock
10mg USD 84 In stock
25mg USD 178 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZD3463 is a novel inhibitor of ALK which overcomes multiple mechanisms of acquired resistance to crizotinib. AZD3463 inhibits ALK with a Ki value of 0.75 nM. AZD3463 dose-dependently inhibits pALK in tumor xenografts in vivo, resulting in stasis (H3122) or regression (DEL, H2228) in tumor volume. AZD3463 obtains equivalent potency to mutantL1196M and wild-type ALK in vivo.

Customer Product Validations & Biological Datas
Source Sci Rep (2016). Figure 2. AZD3463
Method colony formation assay
Cell Lines NB cells
Concentrations 5 μM
Incubation Time 4 hrs
Results Our data indicates that AZD3463 effectively blocks both anchorage-dependent and independent colony formation of NB cells.
Chemical Information
Molecular Weight 448.95
Formula C24H25ClN6O
CAS Number 1356962-20-3
Solubility (25°C) DMSO 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wenxin He, et al. Combination of AZD3463 and DZNep Prevents Bone Metastasis of Breast Cancer by Suppressing Akt Signaling

[2] Neslihan Pınar Ozates, et al. Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer

[3] Bakiye Goker Bagca, et al. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells

[4] Aycan Asik, et al. Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells

[5] Guang-Fu Hu, et al. AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway

Related ALK Products
AP26113 (Brigatinib)

AP26113 (Brigatinib) is a highly potent ALK inhibitor with IC50 of 0.6 nM.

X-376

X-376 is a potent and highly specific ALK small molecule tyrosine kinase inhibitor with IC50 of 0.61 nM.

SB431542

SB-431542 is a potent and selective inhibitor of the transforming growth factor-β (TGF-β) type I receptor activin receptor-like kinase ALK5 (IC50 = 94 nM).

RepSox

RepSox (ALK5 Inhibitor II) is a potent and ATP-competitive inhibitor of the TGF-β type I receptor ALK5 (IC50 values are 0.004 and 0.023 μM for ALK5 autophosphorylation and ALK5 binding respectively).

LDN-193189

LDN-193189 is a highly potent small molecule inhibitor of bone morphogenetic protein (BMP) type I receptors ALK2 and ALK3.

  Catalog
Abmole Inhibitor Catalog




Keywords: AZD3463, ALK/IGF1R inhibitor supplier, ALK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.